Biological Safety and Pandemic Resilience

Extensive epidemiological studies by Harvard University, Johns Hopkins Medicine, the Pasteur Institute, the LSHTM, the University of Arizona, the University of Houston, Imperial College London, the Tokyo University of Science, the Danish Veterinary and Food Administration (AGES), and the Robert Koch Institute (RKI) unanimously confirm the critical fact that footwear is one of the most aggressive "Trojan horses" for hospital and community-acquired infections, invisibly harboring resistant pathogens (MRSA) and superbugs in its deep grooves, even into the most strictly protected sterile zones. Modeling of global infection chains proves that passive defense has failed: saturated mats become secondary infection reservoirs, continuously re-contaminating floor surfaces.
JetMat offers a solution to these critical risks: through validated, automated decontamination at the source, it can block the spread of nosocomial infections and pandemic risks at airlock boundaries, drastically reducing care costs and legal liability. The application of JetMat is not merely a hygiene choice but a strategic pillar of institutional biological security, supporting compliance with WHO, NHS, CDC, and ECDC infection control guidelines, as well as international accreditation standards (JCI). This allows institutions to drastically reduce supply costs and legal liability while ensuring the highest level of patient safety.

1. HOSPITAL NOSOCOMIAL DEFENSE

Please, wait 5 secounds, ... presentations are loading!
Analysis of the efficacy of nosocomial infections and sterile airlock systems. Research by Johns Hopkins, Mayo Clinic, the American Hospital Association (AHA), and the NHS focuses on the protection of operating rooms, intensive care units, and sterile zones, where pathogens carried by footwear (e.g., E. coli, C. diff) and aerosol-generation risks require priority attention to avoid surgical site infections (SSI).
Analysis of hospital-acquired infections (SSI, MRSA) and the role of floors as hidden reservoirs.
Preventing microbial transfer via footwear is essential for maintaining sterility.
Protection of immunocompromised patients and hospital infection chains.
Studies validate the efficacy of active technological defense systems against resistant strains in clinical settings. 
Surgical infection prevention, automated sluicing, and ICU floor-level risks.
Investigations analyze the drastic improvement of patient safety metrics using proactive zone protection technologies. 

2. Global Biosecurity and Pandemic Prevention

Research aimed at biological safety in high-traffic transport hubs and preventing the intercontinental spread of superbugs. Epidemiological modeling by the Pasteur Institute, LSHTM, CDC, and ECDC analyzes the epidemiological vulnerability of metropolitan hubs and the applicability of official biosecurity protocols (e.g., IATA, ACI) to break infection chains.
Zoonoses and urban spread of superbugs.
Research from LSHTM and the Pasteur Institute analyzes biological loads and transfer mechanisms in major metropolitan hubs.
Biological load of urban public spaces, macroeconomic risks, and airport protection.
Emphasizes the importance of infrastructural protection for transport hubs against pandemics.
Biostatistical modeling of infection vectors and community transmission chains.
Based on clinical data, demonstrates the importance of office transfer chains and primary prevention.

3. Microbial Biofilm Management

Elimination of resistant bacterial biofilms forming on footwear soles. Research by the Tokyo University of Science, Clinical Microbiology Reviews, the Pasteur Institute, and ISSA examines technological and microbiological solutions for fighting polymer matrices, proving that biofilm layers require a special approach demanding mechanical and chemical efficacy for effective disinfection.
Biofilm resistance, biofilm formation on footwear, and contamination retention.
Examines the technological challenges of fighting polymer matrices formed by bacteria.
Microbiological risks, fungal infections, and staff turnover.
Analyzes the correlation between infections and staff satisfaction in hospital environments.
IATA safety directives, passenger safety guidelines, and infection source surveillance.
Details the management of biological risks in community and hospital spaces.

4. Automated Sluicing Standards

Determination of automated airlock norms. Investigations by the WHO, NHS, ISSA, and IAEA analyze the creation of technological standards expected in various industries, as well as their validation and auditability, which serves as the basis for future official compliance, ensuring continuous, documented safety in healthcare environments.
Dental aerosol risks, HACCP audits, and slaughterhouse cross-contamination.
Investigates the establishment of automated decontamination standards required in various industries.
Future biosecurity standards, hotel lobby cleanliness, and microplastics.
Describes the connection between cleaning technologies and audit compliance.
Forensic trace analysis, marine biosecurity, and office microplastics.
Discusses audit standards for footwear as vectors and technological solutions against them.